Your browser doesn't support javascript.
loading
The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
Weston, Sam; Macdonald, Joanne L; Williams, Lynn M; Roussou, Euthalia; Kang, Norbert V; Kiriakidis, Serafim; Taylor, Peter C.
Afiliação
  • Weston S; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.
  • Macdonald JL; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.
  • Williams LM; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.
  • Roussou E; King George Hospital, Ilford, Essex, UK.
  • Kang NV; Royal Free Hospital, Hampstead, London, UK.
  • Kiriakidis S; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.
  • Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK. peter.taylor@kennedy.ox.ac.uk.
Clin Exp Rheumatol ; 40(9): 1620-1628, 2022 Sep.
Article em En | MEDLINE | ID: mdl-34665696

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sinoviócitos / Inibidores de Janus Quinases Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sinoviócitos / Inibidores de Janus Quinases Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article